Pengembangan dan Validasi Kuesioner untuk Menilai Miskonsepsi tentang Pengobatan pada Hipertensi dan Diabetes Melitus dengan Kejadian Gagal Ginjal

Irwan Nuryana Kurniawan, Rahma Yuantari, Endang Sulistyowatiningsih, Ani Khotul Faizah, Vitarani Dwi Ananda Ningrum

Abstrak


Miskonsepsi tentang pengobatan menjadi salah satu faktor tingginya ketidakpatuhan pengobatan. Masyarakat beranggapan bahwa penggunaan obat rutin pada hipertensi dan diabetes mellitus (DM) dapat menyebabkan gagal ginjal. Penelitian ini bertujuan untuk menyediakan kuesioner valid dan reliabel yang dapat digunakan untuk mengukur miskonsepsi masyarakat tentang pengobatan jangka panjang pada hipertensi dan DM dengan kejadian gagal ginjal. Pengembangan kuesioner dilakukan dalam 5 tahap yakni konseptualisasi, konstruksi alat ukur, uji coba melalui studi 1 pada 240 mahasiswa/i medis dan non-medis, dan studi 2 pada 300 masyarakat di wilayah Kabupaten Sleman, tes revisi dan selanjutnya tahap analisis melalui uji reliabilitas alpha cronbach. Sementara itu, uji validitas dilakukan dengan membandingkan kuesioner ini dengan kuesioner terpercaya lainnya. Hasil skala pengetahuan tentang terapi hipertensi dan DM terkait kejadian gagal ginjal pada studi 1 dan studi 2 tersusun atas 4 variabel pengetahuan meliputi: pengetahuan terapi hipertensi dan DMT (α 0.742, α 823), miskonsepsi penggunaan obat rutin (α 0.835, α 0.805), pengetahuan obat penyebab gagal ginjal (α 0.582), (α 0.581), serta pengetahuan faktor risiko gagal ginjal (α  0.721, α 0.698). Hasil analisis ini menunjukkan bukti awal dan menyediakan instumen valid dan relevan untuk mengukur tingkat miskonsepsi masyarakat tentang pengobatan jangka panjang pada hipertensi dan DM terkait dengan gagal ginjal.

Kata Kunci


pengembangan dan validasi; kuesioner; miskonsepsi pengobatan; diabetes melitus; hipertensi

Teks Lengkap:

PDF

Referensi


REFERENSI

Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al. Barriers to Insulin Initiation: The Translating Research Into Action for Diabetes Insulin Starts Project. Diabetes Care 2010;33:733–5. https://doi.org/10.2337/dc09-1184.

4.-Konsensus-Pengelolaan-dan-Pencegahan-Diabetes-melitus-tipe-2-di-Indonesia-PERKENI-2015.pdf n.d.

hasil-riskesdas-2018.pdf n.d.

da Costa FA, Pedro AR, Teixeira I, Bragança F, da Silva JA, Cabrita J. Primary non-adherence in Portugal: findings and implications. Int J Clin Pharm 2015;37:626–35. https://doi.org/10.1007/s11096-015-0108-1.

Raebel MA, Carroll NM, Ellis JL, Schroeder EB, Bayliss EA. Importance of Including Early Non-adherence in Estimations of Medication Adherence. Ann Pharmacother 2011;45:1053–60. https://doi.org/10.1345/aph.1Q146.

Paasche‐Orlow MK, Shaykevich S, Cohen MJ, Cohen MJ, Cawthon C, Schnipper JL, et al. Predictors of medication adherence postdischarge: The impact of patient age, insurance status, and prior adherence. Journal of Hospital Medicine 2012;7. https://doi.org/10.1002/jhm.1940.

Tun NN, Arunagirinathan G, Munshi SK, Pappachan JM. Diabetes mellitus and stroke: A clinical update. World J Diabetes 2017;8:235–48. https://doi.org/10.4239/wjd.v8.i6.235.

Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol 2018;34:575–84. https://doi.org/10.1016/j.cjca.2017.12.005.

Ningrum VDA, Ikawati Z, Sadewa AH, Ikhsan MR. Kontrol Glikemik dan Prevalensi Gagal Ginjal Kronik pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Wilayah Provinsi DIY Tahun 2015. Indonesian Journal of Clinical Pharmacy 2017;6:78–90. https://doi.org/10.15416/ijcp.2017.6.2.78.

Chamroonsawasdi K, Chottanapund S, Tunyasitthisundhorn P, Phokaewsuksa N, Ruksujarit T, Phasuksathaporn P. Development and Validation of a Questionnaire to Assess Knowledge, Threat and Coping Appraisal, and Intention to Practice Healthy Behaviors Related to Non-Communicable Diseases in the Thai Population. Behav Sci (Basel) 2017;7. https://doi.org/10.3390/bs7020020.

Eigenmann C, Skinner T, Colagiuri R. Development and validation of a diabetes knowledge questionnaire. Pract Diab Int 2011;28:166–170d. https://doi.org/10.1002/pdi.1586.

Wright JA, Wallston KA, Elasy TA, Ikizler TA, Cavanaugh KL. Development and Results of a Kidney Disease Knowledge Survey Given to Patients With CKD. Am J Kidney Dis 2011;57:387–95. https://doi.org/10.1053/j.ajkd.2010.09.018.

Devins GM, Binik YM, Mandin H, Letourneau PK, Hollomby DJ, Barre PE, et al. The Kidney Disease Questionnaire: a test for measuring patient knowledge about end-stage renal disease. J Clin Epidemiol 1990;43:297–307.

Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health 1999;14:1–24. https://doi.org/10.1080/08870449908407311.

Osborne J, Costello A. Sample size and subject to item ratio in principal components analysis. Practical Assessment, Research, and Evaluation 2019;9. https://doi.org/10.7275/ktzq-jq66.

Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth 2017;11:S80–9. https://doi.org/10.4103/sja.SJA_203_17.

Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care 2003;15:261–6. https://doi.org/10.1093/intqhc/mzg031.

Correia JC, Lachat S, Lagger G, Chappuis F, Golay A, Beran D, et al. Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review. BMC Public Health 2019;19:1542. https://doi.org/10.1186/s12889-019-7842-6.

Moosa A, Bezuidenhout S, Meyer JC, Godman B. Knowledge regarding medicines management of type 2 diabetes amongst patients attending a Community Health Centre in South Africa. Journal of Pharmaceutical Health Services Research 2019;10:13–28. https://doi.org/10.1111/jphs.12283.

Adams OP, Carter AO. Knowledge, attitudes, practices, and barriers reported by patients receiving diabetes and hypertension primary health care in Barbados: a focus group study. BMC Family Practice 2011;12:135. https://doi.org/10.1186/1471-2296-12-135.

Ghane Shahrbaf F, Assadi F. Drug-induced renal disorders. J Renal Inj Prev 2015;4:57–60. https://doi.org/10.12861/jrip.2015.12.

Roomizadeh P, Taheri D, Abedini A, Mortazavi M, Larry M, Mehdikhani B, et al. Limited knowledge of chronic kidney disease and its main risk factors among Iranian community: an appeal for promoting national public health education programs. Int J Health Policy Manag 2014;2:161–6. https://doi.org/10.15171/ijhpm.2014.37.

Alvis Zibran M, Mohammadnezhad M. Management of Type 2 Diabetes and Chronic Kidney Disease in Fiji in 2018: Knowledge, Attitude, and Practice of Patients. Rev Diabet Stud 2019;15:26–34. https://doi.org/10.1900/RDS.2019.15.26.

Collins AJ, Gilbertson DT, Snyder JJ, Chen S-C, Foley RN. Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program. Nephrology (Carlton) 2010;15 Suppl 2:37–42. https://doi.org/10.1111/j.1440-1797.2010.01312.x.

Kumela Goro K, Desalegn Wolide A, Kerga Dibaba F, Gashe Fufa F, Wakjira Garedow A, Edilu Tufa B, et al. Patient Awareness, Prevalence, and Risk Factors of Chronic Kidney Disease among Diabetes Mellitus and Hypertensive Patients at Jimma University Medical Center, Ethiopia. Biomed Res Int 2019;2019. https://doi.org/10.1155/2019/2383508.

Hwang S-J, Tsai J-C, Chen H-C. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton) 2010;15 Suppl 2:3–9. https://doi.org/10.1111/j.1440-1797.2010.01304.x.

Vika V, Siagian M, Wangge G. Validity and reliability of Morisky Medication Adherence Scale 8 Bahasa version to measure statin adherence among military pilots. Health Science Journal of Indonesia 2016;7:129-133–133. https://doi.org/10.22435/hsji.v7i2.5343.129-133.




DOI: https://doi.org/10.25077/jsfk.7.3.202-209.2020

Article Metrics

Abstract view : 497 times
PDF view/download : 277 times



Jurnal Sains Farmasi & Klinis (J Sains Farm Klin) | p-ISSN: 2407-7062 | e-ISSN: 2442-5435

Diterbitkan oleh Fakultas Farmasi Universitas Andalas bekerjasama dengan Ikatan Apoteker Indonesia - Daerah Sumatera Barat 

      

 JSFK is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.